Herophilus is a San Francisco based neurotherapeutics development company that employs AI-driven phenotypic screening to discover and develop novel drugs for complex brain diseases, disorders for which traditional discovery techniques have proved least successful.
Herophilus industrializes the recent revolution in complex in vitro experimental science, leveraging robotic automation and machine learning, to characterize the etiology and expression of disease at molecular, cellular, and tissue levels. These "deep phenotypes" are exploited to identify novel therapeutic targets and drug treatments.
Company Details
- Employees
- 7
- Founded
- -
- Address
- Dogpatch, San Francisco,california 94107,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- system1.bio
- HQ
- San Francisco, California
Herophilus Questions
Herophilus's website is system1.bio
Herophilus's LinkedIn profile is https://www.linkedin.com/company/herophilus
Herophilus has
7 employees.
View email and phone details for 7
employees at Herophilus.
Herophilus's industry is
Biotechnology Research
Herophilus's top competitors are
Genentech,
Opal Therapeutics,
Neuromatch,
Chai Discovery,
Loki Therapeutics,
Parallel Bio,
Centivax,
Recursion,
Mutagentech,
Verge Genomics.
Herophilus's categories are Biotechnology Research
Herophilus's founding year is 2017
